Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2008 1
2009 2
2010 3
2014 1
2016 2
2017 1
2018 1
2019 3
2020 1
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.
van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, Van den Bosch F, Sieper J, Tomita T, Landewé R, Zhao F, Krishnan E, Adams DH, Pangallo B, Carlier H; COAST-V study group. van der Heijde D, et al. Lancet. 2018 Dec 8;392(10163):2441-2451. doi: 10.1016/S0140-6736(18)31946-9. Epub 2018 Oct 22. Lancet. 2018. PMID: 30360964 Clinical Trial.
Fracture risk assessment in Latin America: is Frax an adaptable instrument for the region?
Morales-Torres J, Clark P, Delezé-Hinojosa M, Cons-Molina F, Messina OD, Hernández J, Jaller-Raad JJ, Quevedo-Solidoro H, Radominski SC. Morales-Torres J, et al. Among authors: cons molina f. Clin Rheumatol. 2010 Oct;29(10):1085-91. doi: 10.1007/s10067-010-1489-0. Epub 2010 Jul 15. Clin Rheumatol. 2010. PMID: 20632196 Review.
Serum irisin concentrations and osteoporotic vertebral fractures in women with rheumatoid arthritis: A cross-sectional study.
Gamez-Nava JI, Ramirez-Villafaña M, Cons-Molina F, Gomez-Ramirez EE, Esparza-Guerrero Y, Saldaña-Cruz AM, Sanchez-Rodriguez EN, Jacobo-Cuevas H, Totsuka-Sutto SE, Perez-Guerrero EE, Huerta M, Trujillo X, Vasquez-Jimenez JC, Nava-Zavala AH, Cardona-Muñoz EG, Alcaraz-Lopez MF, Gonzalez-Lopez L. Gamez-Nava JI, et al. Among authors: cons molina f. Medicine (Baltimore). 2022 Feb 11;101(6):e28799. doi: 10.1097/MD.0000000000028799. Medicine (Baltimore). 2022. PMID: 35147113 Free PMC article.
Risk Factors of Muscle Wasting in Women with Rheumatoid Arthritis: Relevance of the Persistent Failure of Conventional Combination Therapy.
Gomez-Ramirez EE, Ramirez-Villafaña M, Gamez-Nava JI, Cons-Molina F, Rodriguez Jimenez NA, Saldaña-Cruz AM, Cardona-Muñoz EG, Totsuka-Sutto SE, Ponce-Guarneros JM, Trujillo X, Huerta M, Cruz-Jentoft AJ, Gonzalez-Lopez L. Gomez-Ramirez EE, et al. Among authors: cons molina f. Healthcare (Basel). 2022 Oct 11;10(10):2004. doi: 10.3390/healthcare10102004. Healthcare (Basel). 2022. PMID: 36292451 Free PMC article.
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y).
Landewé RB, Gensler LS, Poddubnyy D, Rahman P, Hojnik M, Li X, Liu Leage S, Adams D, Carlier H, Van den Bosch F; COAST-Y study group. Landewé RB, et al. Ann Rheum Dis. 2021 Aug;80(8):1022-1030. doi: 10.1136/annrheumdis-2020-219717. Epub 2021 May 6. Ann Rheum Dis. 2021. PMID: 33958326 Free PMC article. Clinical Trial.
The prevalence of radiographic vertebral fractures in Mexican men.
Clark P, Cons-Molina F, Deleze M, Talavera JO, Palermo L, Cummings SO. Clark P, et al. Among authors: cons molina f. Osteoporos Int. 2010 Sep;21(9):1523-8. doi: 10.1007/s00198-009-1109-5. Epub 2009 Nov 21. Osteoporos Int. 2010. PMID: 19936869 Free PMC article.
Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial.
Shim SC, Božić-Majstorović L, Berrocal Kasay A, El-Khouri EC, Irazoque-Palazuelos F, Cons Molina FF, Medina-Rodriguez FG, Miranda P, Shesternya P, Chavez-Corrales J, Wiland P, Jeka S, Garmish O, Hrycaj P, Fomina N, Park W, Suh CH, Lee SJ, Lee SY, Bae YJ, Yoo DH. Shim SC, et al. Among authors: cons molina ff. Rheumatology (Oxford). 2019 Dec 1;58(12):2193-2202. doi: 10.1093/rheumatology/kez152. Rheumatology (Oxford). 2019. PMID: 31184752 Free PMC article. Clinical Trial.
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors.
Deodhar A, Poddubnyy D, Pacheco-Tena C, Salvarani C, Lespessailles E, Rahman P, Järvinen P, Sanchez-Burson J, Gaffney K, Lee EB, Krishnan E, Santisteban S, Li X, Zhao F, Carlier H, Reveille JD; COAST-W Study Group. Deodhar A, et al. Arthritis Rheumatol. 2019 Apr;71(4):599-611. doi: 10.1002/art.40753. Epub 2019 Mar 8. Arthritis Rheumatol. 2019. PMID: 30343531 Free PMC article. Clinical Trial.
17 results